Crestor's arrival raises pulse in drug industry

Article Abstract:

The article discusses Crestor, the new cholesterol medication made by AstraZeneca PLC. Crestor is now in late-stage development and is slated to debut in the U.S. next year. The company is deliberating whether to choose a U.S. partner for the launch.

United Kingdom, Product introduction, Lipotropics & Cholesterol Reducers, AstraZeneca PLC, AZN

---

Scaled up: Biggest drug firm faces generics, but has an edge -- its very bigness

Article Abstract:

Pfizer Inc. braces for a major dip in sales as three of its best-selling drugs are soon to lose patent protection. However, the company is confident that it can weather the loss and come out ahead by using its size and considerable market power to successfully launch a slew of new medications and to negotiate lucrative agreements with drug insurance providers.

Strategy & planning, Drugs & Pharmaceuticals, Pharmaceutical and Medicine Manufacturing, Contracts & orders received, Commodity & service prices, Drugs, Pharmaceutical Preparations, Metabolic Agents NEC, Contracts & orders let, Metabolic Agents, Prices and rates, Contracts, Contract agreement, Company pricing policy, Aims and objectives

---

Side effects: as generics pummel its drugs, Pfizer faces uncertain future

Article Abstract:

As employee benefit plans and health insurers direct their patients to take generic drugs, pharamceutical companies such as Pfizer Inc. are seeing their hold on the market weaken. Even such products as Pfizer's cholesterol reducing drug Lipitor are losing market share before their patents run out. Pfizer is responding to the growing presence of generic drugs by stepping up its marketing efforts and pinning its hopes on several new products.

Sales, profits & dividends, Forecasts, trends, outlooks, Marketing procedures, Market share, Generic Drugs, Forecasts and trends, Marketing, Market trend/market analysis, Company sales and earnings, Company earnings/profit, Employee benefits, Brand name products, Brand names, Company marketing practices, Product marketing strategy, Product market share, Company market share, McKinnell, Henry, Lipitor (Medication)

Similar abstracts:

• Abstracts: Spruced up: old-line retailer learns new tricks to evade takeover. Europe's E-Tailers Get Back to Basics
• Abstracts: U.S. is setting a path for biotech generics: regulator plots a course for approving copycats of bioengineered medicines
• Abstracts: Fueled by oil money, Russian economy soars: an investment boom transforms industries; Bor's barter days over. Sibneft creates real-time market for oil deals
• Abstracts: Hynix, Micron mull tie-up: Chip makers could form global DRAM giant. Hynix's creditor accord tied to level of new financing
• Abstracts: Granada seeks alliances as part of expansion goal for Europe. Carlton nears deal on purchase of Screenvision

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.